| Net revenue | |
| Cost of sales | 1.25B |
| Gross margin | 59M |
| Research and development | 259M |
| Marketing, general and administrative | 117M |
| Amortization of acquired intangible assets | 0 |
| Restructuring reversals | |
| Operating income | -293M |
| Interest income | |
| Interest expense | -41M |
| Other income (expense), net | -63M |
| Income before equity income (loss) and dilution gain in investee and income taxes | -397M |
| Provision (benefit) for income taxes | 4M |
| Equity income (loss) and dilution gain in investee, net | -5M |
| Net income (loss) | |
| Basic | -0.5 |
| Diluted | -0.5 |
| Basic | 815M |
| Diluted | 815M |